[Federal Register Volume 75, Number 83 (Friday, April 30, 2010)]
[Notices]
[Page 22844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-10116]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 16, 2010, Lonza
Riverside, 900 River Road, Conshohocken, Pennsylvania 19428, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)........... I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
------------------------------------------------------------------------
The company plans to manufacture bulk active pharmaceutical
ingredients (APIs) for distribution to its customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than June 29, 2010.
Dated: April 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-10116 Filed 4-29-10; 8:45 am]
BILLING CODE 4410-09-P